Sign In

Mission Delivery

Breaking News

Watch the Colorectal Cancer Awareness Month webcast

Throughout March, the American Cancer Society National Colorectal Cancer Roundtable (ACS NCCRT) has been sharing content around three calls to action to support colorectal cancer (CRC) awareness: get screened, encourage your loved ones to get screened, and leverage ACS NCCRT resources to increase CRC screening and drive awareness in your community. 

Each year, the ACS NCCRT hosts its National Colorectal Cancer Awareness Month webcast celebrating national CRC achievements and covering the latest state of the field updates that inform the ACS NCCRT’s work as well as the work of its partners and members. 

The recording of the 2025 webcast, which took place on March 12, is available now

In the recording, you’ll hear from: 

  • Dr. Priti Bandi, scientific director, Risk Factors & Screening Research, American Cancer Society
  • Other special guests like the 2025 ACS NCCRT National Achievement Awards honorees.

  • ACS NCCRT chair and vice-chair, Steven Itzkowitz, MD, FACP, FACG, AGAF, and Gloria Coronado, PhD

Follow the ACS NCCRT on LinkedIn and X to stay up to date on roundtable news and engagement opportunities. 

The ACS National Roundtables are a recommended and proven model for creating sustained partnerships across diverse sectors and communities to collaboratively address the most complex problems across the cancer continuum. ACS provides organizational leadership and expertise to support the roundtables and their members in advancing a shared commitment to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. 

  • Patient Support Pillar releases annual impact report

    ​The Patient Support Pillar is excited to release its second annual Patient Support Impact Report. The report is themed “Bold Together” to recognize our commitment to every person with cancer and their families and the collaboration and teamwork it takes to achieve our ambitious goals. It covers our program of work in cancer care, reducing the risk of cancer, and cancer navigation. 

    ​Inside this interactive digital report, you’ll find details on some of our key successes this past year, including: 

    • ​Reaching 111 million lives, providing critical support to people facing cancer and their families through essential programs, services, and expert information. 
    • Saving $73 million in hotel costs for people facing cancer through our Hope Lodge communities, ensuring no one faces cancer alone.
    • A celebration of the thousands of people facing cancer served by our transportation programs, ensuring that not having a ride never gets in the way of making it to critical appointments. 
    • Exciting reporting on how we addressed food and financial insecurity, and interruptions to cancer care so people facing cancer can continue treatment. 
    • An ambitious new program that is leading the field of professional patient navigation, ACS LION. 
    • Our efforts to make cancer information more understandable and easier to find for anyone who needs it. 
    • A mini documentary celebrating the patients who found a home away from home in our Hope Lodge locations. 
    • ​Sneak peeks into some of the bold new initiatives we have planned for 2025. 
    How You Can Help 

    All team members and volunteers are encouraged to amplify social media posts made by the enterprise and the Patient Support Senior Leadership Team on LinkedIn​ over the coming days and weeks. You can select the repost option and share your comments indicating your involvement in the work. Team members and volunteers are also encouraged to share the report with partners in your network.​​

  • Global Cancer Patient Support receives Merck Foundation grant

    ​On Feb. 27, ACS launched a new initiative – SPARK (Supporting Patient Navigation, Adoption, Replication and Knowledge-exchange) – to strengthen and enhance patient navigation and improve care for people living with cancer in Indonesia, Kenya, and Nigeria. This initiative is supported by a six-year, $3.5 million commitment in grant funding from the Merck Foundation, a private charitable organization funded by Merck & Co., Inc., Rahway, NJ USA (known as MSD Foundation outside the United States and Canada). 

    SPARK builds on and extends ACS’ groundbreaking work to develop cancer patient navigation in low-and-middle-income countries (LMICs) through the ACS BEACON (Building Expertise, Advocacy and Capacity for Oncology Navigation) Initiative. Participating health institutions and cancer organizations navigated more than 152,000 patients globally in 2024. While the BEACON Initiative supports efforts to pioneer patient navigation at the country level, SPARK will build the capacity of multiple health facilities and cancer organizations in national cancer care delivery systems in Indonesia, Kenya, and Nigeria to enhance access to care for more patients throughout each country. 

    “The global burden of cancer is expected to almost double in the next three decades, with the largest burden of increased cancer incidence and mortality in countries with lower resources. With a scale-up of cancer services in these settings, we have an opportunity to positively change these outcomes,” said Dr. Arif Kamal, chief patient officer. “Patient navigation is a proven, effective method to increase equitable access to cancer care in the United States, and we at the American Cancer Society have a rich history of translating domestic lessons learned to other countries. We are excited to expand this collaborative work so more patients across the globe can access high-quality care through navigation.” 

    According to ACS’ 2024 Global Cancer Facts & Figures, an estimated 20 million cancer cases were newly diagnosed and 9.7 million people died from their disease worldwide in 2022. By 2050, the number of new cancer cases is predicted to reach 35 million. Seventy percent of these deaths are in LMICs, primarily due to lack of or inadequate early detection and treatment services. For example, the breast cancer mortality rate is twice as high in Nigeria as in the United States (27 versus 12 per 100,000) despite a 48% lower incidence rate (52 versus 100 per 100,000). 

    "In a country as vast as Indonesia, where access to care is a challenge along with other complex barriers to care, we must bring patient-centered solutions closer to patients needing them most. SPARK provides us with an opportunity to expand patient navigation partnerships between regional hospitals and local cancer organizations to ensure that every patient receives timely and effective diagnosis and treatment," said Dr. Soehartati A. Gondhowiardjo: Cipto Mangunkusumo National Referral Hospital, Indonesia. 

    With support from the Merck Foundation, SPARK will apply the capacity development resources and efforts of the BEACON Initiative to develop a robust network of patient navigation programs at the sub-national level. SPARK will promote a groundswell of interest and awareness in patient navigation by building the capacity of local cancer organizations and health facility partners, promoting connections and collaborative efforts, and guiding governmental policy efforts in each country to prioritize and sustain patient navigation as essential for equitable and accessible high-quality patient care. 

    “Strong collaborators and innovative solutions are needed to improve cancer care. The Merck Foundation is proud to support the American Cancer Society in their efforts to advance patient navigation, ensuring more individuals in underserved communities receive the vital assistance they need on their cancer journey,” said Kalahn Taylor-Clark, vice president and head of Social Impact and Sustainability at Merck Foundation. 

    Learn more about the American Cancer Society’s Global cancer work and the BEACON Initiative on cancer.org

  • ACS NCCRT honors National Achievement Award winners

    ​Raising colorectal cancer screening rates is more critical than ever as incidence grows among people younger than 55 years of age. The findings in the American Cancer Society’s recent Cancer Facts & Figures, 2025 report show colorectal cancer death rates have been increasing by about 1% each year since the mid-2000s for people under 55 years old.  
    The American Cancer Society National Colorectal Cancer Roundtable (ACS NCCRT), founded in partnership with the Centers for Disease Control and Prevention, honored five organizations for their extraordinary work to increase colorectal cancer screening rates across the U.S. with the 2025 ACS NCCRT National Achievement Award. Like and share the news on X

    “The call to increase colorectal cancer screening rates has never been more urgent than today and we applaud our honorees who have stepped up to help save lives,” said Steven Itzkowitz, MD, FACP, FACG, AGAF, gastroenterologist with the Icahn School of Medicine at Mount Sinai, and ACS NCCRT chair. “We are proud of the work our honorees have done and will continue to do in the fight to reduce the incidence of and mortality from colorectal cancer and make progress toward our shared goal to increase screening rates to 80% or higher.” ​ 
    The ACS NCCRT National Achievement Award honors individuals and organizations who dedicate their time, talent, and expertise to advancing initiatives that support the shared goal to increase colorectal screening rates in communities across the nation. The awards include one grand prize winner and four other honorees, each of whom receives a monetary award to support continued efforts to increase colorectal cancer screenings. ​

    This year's recipients are: Erie Family Health Centers, Chicago, IL; Georgia Center for Oncology Research and Education, GA; Marshall, El Dorado County, CA; Peoples Health, LA; Project 80% at the University of Texas MD Anderson Cancer Center, Central, East, Southeast, and West TX and the Rio Grande Valley. Read more about their work below. 

    Grand Prize Winner: Erie Family Health Centers

    ​Category: Federally Qualified Health Center 

    Erie Family Health Centers (Erie) is a Federally Qualified Health Center (FQHC) that serves more than 95,000 patients at 13 locations across Chicago, IL and its northern suburbs. Eighty-eight percent of Erie patients are either Medicaid recipients or uninsured, and 45% speak languages other than English. Erie aimed to increase access to and rates of colorectal cancer (CRC) screening as well as ensure pathways to follow-up colonoscopies for patients aged 45 and above, specifically focusing on never-screened individuals. At the start of the project in 2023, Erie’s overall screening rate was 49%. Just one year later, their rate jumped to 59%. 16,603 patients were screened for CRC during the project period. Erie’s tactics are multi-pronged and thoughtfully coordinated, combining tailored community and provider education, marketing campaigns, direct patient outreach, appointment and financial navigation support, transportation assistance, and strong partnerships with local health systems to help remove barriers to screening and follow-up care. Erie is proud to have expanded CRC care to patients ages 45-49 earlier than required and is committed to continuing this work to improve access to CRC screening and care for medically underserved communities in the Chicago area. 

    ​ACS Regional Involvement: Gargee Patel, associate director, community partnerships, works with Erie Family Health Centers in Chicago, IL. ​​

    Honoree: Georgia Center for Oncology Research and Education

    Category: Colorectal Cancer Control Program (CRCCP)

    Georgia Center for Oncology Research and Education (Georgia CORE), a unique statewide organization formed in 2003, became a recipient of the Centers for Disease Control and Prevention’s (CDC’s) Colorectal Cancer Control Program (CRCCP) grant in 2020, and formed a collaborative partnership with Augusta University and Horizons, South Georgia’s Cancer Coalition. Together they built a program that includes 20 clinics in 18 counties from three separate Federally Qualified Health Centers (FQHCs) to offer free CRC screening to eligible patients in a mostly rural and largely underserved area, employing five evidence-based interventions to increase screening. Of note, the partnership launched Augusta University’s TeleECHO CRC Screening project that has held 22 sessions since 2022, educating providers about how to increase CRC screening rates. Between 2021 and 2023, CRC screening rates in southeast Georgia rose from 34% to 45%, increasing 11 percentage points in just two years. Furthermore, in southwest Georgia, participating clinics screened more than 1,500 more patients for CRC in 2023 (6,309 screened versus 4,748 in 2022). They are most proud of building diverse and collaborative partnerships to best serve rural Georgians, including with FQHCs, health systems, an academic institution, and a regional cancer coalition.     

    ACS Regional Involvement: Kylie Jupp, associate director, state partnerships, has worked closely with Georgia CORE over the past few years, including nominating them for this honor.  ​

    Honoree: Marshall 
    Category: Health System ​​​
    Marshall is a health system located in and serving El Dorado County, CA, with a particular focus on engaging their rural community, the most vulnerable, and getting those aged 45-49 screened for colorectal cancer (CRC). Over the past year, their overall CRC screening rate rose three percentage points to 82%, while their efforts to impact younger populations (aged 45-49) have increased that age group’s screening rate to 61%, up by 8 percentage points in one year. Supported by a grant from Exact Sciences, Marshall used a multifaceted and tailored approach to reach people for CRC screening, including collaborative community outreach events, small media (including in multiple languages), evidence-based provider and staff education, clinical champion development, standing orders for stool-based tests, enhanced outreach to vulnerable patients, and minimizing financial barriers to screening and care by offering transportation and cost-reduction programs. They are most proud of the close working partnership between their primary care providers, cancer center leaders, and their population health departments, who all came together around the common goal to serve their community and increase CRC screening rates. ​
    ACS Regional Involvement: Jennifer Giese, associate director, cancer center partnerships, works with Marshall in Northern CA. ​

    Honoree: Peoples Health

    Category: Health Plan

    Peoples Health is a Medicare Advantage plan serving over 140,000 members in Louisiana. Through participation in the Louisiana Payors Council (LPC) and as a founding member of the non-profit organization Taking Aim at Cancer in Louisiana (TACL), Peoples Health has prioritized colorectal cancer (CRC) screening within its population and across the state. Chief Medical Officer at Peoples Health, Dr. Brent Wallis, is the Chair of the LPC, which has advocated for unified CRC screening promotion and messaging across all payors, resulting in collaborative one-pagers and a state-wide CRC Screening Registry for Medicaid recipients; and for engaged payors to enact policy change to eliminate copays for a follow-up colonoscopy, even before doing so was required by the Centers for Medicare & Medicaid Services. Peoples Health increased CRC screening rates of its plan members from 50% in 2021 to 54% in 2023, representing almost 28,000 screened members, with many parishes reporting rates over 60%. The organization eliminated screening disparities between Black and White members of its population, resulting in 56% and 53% screening parity, respectively. Peoples Health is proud of taking an “all hands” approach to increasing CRC screening among its health plan members, and in supporting the importance of CRC screening across Louisiana through its participation with TACL.  

    ACS Regional Involvement: Shea Austin, associate director, state partnerships, has worked closely with Dr. Brent Wallis of Peoples Health, as well as the Louisiana Payors Council, over the past few years.  ​​

    Honoree: Project 80% at the University of Texas MD Anderson Cancer Center ​​​​​
    Category: Screening Program 
    ​​Project 80% is a screening program designed to reduce incidence and mortality related to colorectal cancer (CRC) in Central, East, Southeast and West Texas and the Rio Grande Valley, specifically focused in rural and urban health professional shortage areas. Based out of The University of Texas MD Anderson Cancer Center, Project 80% works in partnership with 176 community clinics and Federally Qualified Health Centers (FQHCs) and is supported by funding from the Cancer Prevention and Research Institute of Texas (CPRIT). To date, Project 80% has resulted almost 135,000 fecal immunochemical tests (FITs), culminating in 7,750 colonoscopies completed, which translates to a 75% follow-up rate after an abnormal FIT or direct referral for increased risk participants. The program uses multiple tactics including providing free screening for those without insurance, patient reminders, individual and group education, provider reminders, provider feedback and assessment, as well as reduction of structural barriers through patient navigation provided by Community Health Workers (CHWs) fluent in English and Spanish. They are most proud of how their providers, clinical teams, endoscopy partners, and CHWs have come together to navigate the most vulnerable to CRC screening and the sheer reach they’ve had in their communities over time. 
    ​​​​ACS Regional Involvement: Hannah Hogan, associate director, cancer center partnerships, has worked with MD Anderson Cancer Center during the past few years in Southeast Texas. ​​

  • PAWS program brings joy and calm

    ​From puppyhood, facility dogs – like Mahi, a golden retriever, pictured above – work full-time in children’s hospitals to provide therapeutic interventions and emotional support. They receive extensive, specialized training to provide goal-orientated interactions. 

    “The wonderful thing about dogs is that words aren’t necessary. There’s an instant, unspoken connection,” said Talia Mor, certified child life specialist and facility dog handler at Jackson Health System. “One of my favorite parts has been watching the way patients, families, and staff light up when they see Mahi. Their faces completely transform.” ​

    Read more about Mahi and the other newest facility dog programs that received a 2024 ACS PAWS (Pups Assisting With Support) grant on Cancer Connections, our new ACS blog found on cancer.org. 

    ​​“PAWS funding fills critical gaps for these programs and helps improve cancer outcomes by making our youngest patients more comfortable while undergoing treatment,” said Chief Patient Officer Dr. Arif Kamal.


  • Here’s the bottom line for Colorectal Cancer Awareness Month

    The American Cancer Society is raising awareness about early detection for colorectal cancer during Colorectal Cancer Awareness Month in March. Colorectal cancer is the second leading cause of cancer death in men and women combined. ​Even more alarming, only about 20 percent of people ages 45-49 are getting screened for colorectal cancer. 

    Colorectal Cancer Screening Saves Lives

    Here’s the bottom line: Colorectal cancer has a 91% survival rate when found early. If you’re 45 or older and don’t have symptoms, now is the perfect time to show yourself some love and get screened. 

    Regular colorectal cancer screening can find and remove lesions before they become cancer, and everyone age 45 and older is encouraged to talk to a doctor about colorectal cancer screening. 

    The ACS I Love You Get Screened activation will drive awareness of colorectal cancer and drive people to talk to a doctor and visit cancer.org/getscreened.

    If you’re age 45+, talk to a doctor about colorectal cancer screening. 
    • ​​Share information about screening with your friends and family. 
    • Engage and share information from ACS brand social channels. 
    • Learn more at cancer.org/getscreened. 
    • ​Use the ACS CancerRisk360 tool to assess your risk and share the tool with others. There’s no sure way to prevent colorectal cancer, but you may be able to lower your risk for colorectal cancer by changing the risk factors you can control.
    ​Colorectal Cancer Facts 
    • ​​​Cancer screening is for people without symptoms. 
    • Only 20% of people aged 45-49 years are getting screened for colorectal cancer. 
    • When colorectal cancer is found at an early stage before it has spread, the 5-year relative survival rate is about 90%. 
    • There are several testing options for colorectal cancer screening – the most important thing is to get screened, no matter which test you choose. 
    • About 1 in 3 people in the United States who should get tested for colorectal cancer have never been screened. 
    • Regular colorectal cancer screening can find and remove lesions before they become cancer. 
    • Colorectal cancer is the second most common cause of cancer death in men and women combined. 
    • Screening can prevent colorectal cancer through the detection and removal of precancerous growths (polyps), and it can often detect cancer at an early stage, when treatment is usually more successful. 
    • More than half of all colorectal cancers in the US are attributable to potentially modifiable risk factors, such as smoking, an unhealthy diet, high alcohol consumption, physical inactivity, and excess body weight. 
    • If 80% of the eligible population stayed up to date with screening, more than a quarter of a million (277,000) colorectal cancer cases and 203,000 deaths could be prevented. 

  • Four Hope Lodge locations launch ACS EMPOWER pilots

    The American Cancer Society began to pilot a new program, ACS EMPOWER, to four Hope Lodge locations in December, and there are plans to expand the program to all locations later this year. ACS EMPOWER is an interactive educational wellness and integrative health curriculum focused on improving the quality of life for Hope Lodge guests and those in the local community with cancer. The four pilot locations are Iowa City, IA; Jackson, MS; Jacksonville, FL; and Salt Lake City, UT. 

    “We recognized a need to further support people on their cancer journey, integrating a focus on whole-person health into the Hope Lodge experience; ACS EMPOWER is designed to help people elevate their quality of life by fostering resilience, connection, and well-being,” said Tamara Fernandez, vice president, Hope Lodge.

    ACS EMPOWER curriculum is comprised of seven core areas focused on the holistic well-being of people with cancer: 

    • Engage: Connect to knowledge and support communities, strengthen social networks, combat exclusion, and isolation
    • Move: Strengthen, energize, and destress with physical resilience activities 
    • Play: Harness the power and positive impact of fun at any age; evoke joy and laughter, reduce anxiety, and embrace teamwork 
    • Optimize: Position to achieve and maintain comprehensive physical and physiologic wellness during active treatment and beyond 
    • Waken: Elevate consciousness, unleash creativity, and embrace self-expression to support healing 
    • Enrich: Explore the benefits of complementary, functional, and integrative medicine principles, techniques, and programs 
    • ​Resource: Understand the array and availability of non-clinical support resources and health-related social needs programs. 

    The curriculum will allow each Hope Lodge community to tailor the program to fit the needs of its guests and create meaningful connections within the local community.

    "This program is going to revolutionize the Hope Lodge experience and create a brighter, stronger future for the patients and caregivers we serve,” added Tamara. 

    The varied EMPOWER activities include: 

    • Cooking demonstrations featuring nutritious, cancer-friendly meals 
    • Arts and crafts for creative expression and relaxation 
    • Live music and entertainment to uplift and inspire 
    • Massage therapy to support stress relief and healing 
    • Yoga and stretch exercises to enhance physical well-being 
    • ​Educational lectures on health, nutrition, and survivorship ​
    Looking Ahead 

    With its nationwide expansion planned for later this year, ACS EMPOWER represents a new era of integrative oncology support, ensuring that every Hope Lodge guest has access to comprehensive, whole-person care throughout their cancer journey. 

  • Marking World Cancer Day

    ​​​​​​As reported in our Global Cancer Facts & Figures last year by our Surveillance and Health Equity Science team, the global cancer burden is expected to grow by approximately 80% in the next three decades solely due to the growing and aging of the population. The future burden is likely to be greater than projected because of the adoption of Western lifestyles associated with cancer such an unhealthy diet and physical inactivity. On Feb. 4, the American Cancer Society joins organizations across the globe in uniting around World Cancer Day to make an impact on the growing cancer burden. 

    Planned efforts are underway by our Discovery and Patient Support Pillars: 
    • ​With Cancer Research UK and the National Cancer Institute, our Discovery Pillar led the first of a now annual Cancer Prevention Conference​
    • Expanding training for health care workers on the importance of HPV vaccination. 
    • Continuing to grow our network of patient navigation
    • Extending the scope of our African Cancer Coalition
    • Continue research capacity-building work in parts of Africa. 
    • ​​​Release of the fourth edition of The Cancer Atlas
    • Aligned with the United Nations Sustainable Development goal for 2025, Global Cancer Support will grow our collaborative partnerships worldwide to improve equitable patient access to prevention, screening, cancer treatment, and higher quality health systems and better-trained health care providers through new initiatives: 
      • ​​Launch of the Global Alliance for Cancer Patient Navigation — ACS will lead a global collaborative to unify global principles surrounding patient navigation implementation and capacity development while building awareness of navigation’s vital benefit to patients, caregivers and health systems throughout the world.
      • ​Launch of the ACS Global Academy — ACS will leverage the growing network of worldwide collaborating partners, including our growing Global Relay for Life network, Global Heroes of Hope, and other cancer organizations and civil society partners to deliver technical expertise for unified and collaborative global initiatives.
    Learn more about ACS’ work around the world – and be sure to check out The Cancer Atlas, which includes an interactive online resource where you can discover more by country or trend.​

  • Cancer prevention starts with risk reduction

    ACS will launch its new comprehensive cancer risk assessment tool, ACS CancerRisk360, in February, National Cancer Prevention Month, to help people understand their personal cancer risk factors and steps they can take to reduce that risk. The tool evaluates risk by looking at four key areas: genetic risk, family history, screening adherence, and daily life factors. By better assessing and empowering individuals to take actionable steps based on their personal cancer risk information, we can improve outcomes, including preventing cancer. 

    Building on our long-standing relationship with Pfizer, including the most recent Change the Odds effort, and a long history of support for cancer screening initiatives, we’re once again collaborating to amplify the reach of our ACS CancerRisk360 assessment tool. Beginning in February, the ACS CancerRisk360 will be featured in the Pfizer for All campaign, connecting people directly to resources for better health. This collaboration will help amplify our reach and drive the utilization of the tool.

    Approximately 40% of adult cancer diagnoses in the US are linked to modifiable risk factors. Cancer risk is dependent on several factors, including genetic/hereditary markers, family history of cancer, adherence to evidence-based cancer screening guidelines, and daily life factors such as tobacco use, alcohol consumption, diet, physical activity, and body weight/BMI. While some cancers can’t be prevented, people can reduce their risk by making healthy choices like eating a healthy diet, staying active, and not smoking. 

    What the tool is not: 

    • A risk calculator 
    • A medical device 
    • A replacement for a visit with a doctor or other healthcare professional
    • A research tool/project 

    Team members are encouraged to check your cancer risk at: ACSCancerRisk360.cancer.org. ​

    ​Get Involved

    Research shows that nearly half of all cancers can be linked to risk factors you can change. You can help by: 

    • Take the ACS CancerRisk360 assessment to learn more about what you can change to improve your health and lower your cancer risk.
    • Encourage your network to take the assessment. 
    • Spread the word about the tool by amplifying ACS social media posts in February. ​

back to top